Lipid-lowering therapy with pravastatin reduces coronary plaque volume: Role of high-density lipoprotein cholesterol containing apolipoprotein A-1

被引：0
|
作者：
Tani, S [1 ]
Watanabe, I [1 ]
Oguchi, S [1 ]
Anazawa, T [1 ]
Takahashi, H [1 ]
Nomoto, K [1 ]
Miya, N [1 ]
Ishikawa, K [1 ]
Matsumoto, M [1 ]
Nosaka, T [1 ]
Kobari, T [1 ]
Miyazawa, T [1 ]
Furukawa, K [1 ]
Miyamoto, T [1 ]
Nagao, K [1 ]
Kanmatsuse, K [1 ]
机构：
[1] Nihon Univ, Surugadai Hosp, Tokyo, Japan
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2003年 / 41卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：296A / 296A
页数：1
相关论文
共 50 条
  • [31] Baseline low-density lipoprotein cholesterol is an important predictor of the benefit of intensive lipid-lowering therapy
    Giraldez, Roberto R.
    Giugliano, Robert P.
    Mohanavelu, Satishkumar
    Murphy, Sabina A.
    McCabe, Carolyn H.
    Cannon, Christopher P.
    Braunwald, Eugene
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 52 (11) : 914 - 920
  • [32] Association of the Low-Density Lipoprotein Cholesterol/High-Density Lipoprotein Cholesterol Ratio and Body Mass Index with Coronary Plaque Regression
    Tani, Shigemasa
    Matsumoto, Michiaki
    Nakamura, Yasutaka
    Nagao, Ken
    Hirayama, Atsushi
    AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2012, 12 (04) : 279 - 286
  • [33] Association of the Low-Density Lipoprotein Cholesterol/High-Density Lipoprotein Cholesterol Ratio and Body Mass Index with Coronary Plaque Regression
    Shigemasa Tani
    Michiaki Matsumoto
    Yasutaka Nakamura
    Ken Nagao
    Atsushi Hirayama
    American Journal of Cardiovascular Drugs, 2012, 12 (4) : 279 - 286
  • [34] Marked lowering of high-density lipoprotein cholesterol levels due to high dose bexarotene therapy
    Basani, Samata
    Garg, Abhimanyu
    JOURNAL OF CLINICAL LIPIDOLOGY, 2015, 9 (06) : 832 - 836
  • [35] Low High-Density Lipoprotein Cholesterol Is Not a Risk Factor for Recurrent Vascular Events in Patients With Vascular Disease on Intensive Lipid-Lowering Medication
    van de Woestijne, Anton P.
    van der Graaf, Yolanda
    Liem, An-Ho
    Cramer, Maarten J. M.
    Westerink, Jan
    Visseren, Frank L. J.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 62 (20) : 1834 - 1841
  • [36] Dyslipidemia, gender, and the role of high-density lipoprotein cholesterol: Implications for therapy
    Legato, MJ
    AMERICAN JOURNAL OF CARDIOLOGY, 2000, 86 (12A): : 15L - 18L
  • [37] Acrolein inhibits cholesterol transport by high density lipoprotein: Potential role for site specific modification of apolipoprotein A-1 in atherogenesis
    Shao, BH
    McDonald, TO
    O'Brien, KD
    Fu, XY
    Oram, JF
    Heinecke, JW
    CIRCULATION, 2004, 110 (17) : 36 - 36
  • [38] Effects of Lipid-Lowering Drugs on High-Density Lipoprotein Subclasses in Healthy Men-A Randomized Trial
    Berthold, Heiner K.
    Rizzo, Manfredi
    Spenrath, Nadine
    Montalto, Giuseppe
    Krone, Wilhelm
    Gouni-Berthold, Ioanna
    PLOS ONE, 2014, 9 (03):
  • [39] THE IMPACT OF DECREASED HIGH-DENSITY LIPOPROTEIN-CHOLESTEROL LEVEL AFTER LIPID-LOWERING THERAPY ON THE CLINICAL OUTCOMES IN PATIENTS WITH ACUTE CORONARY SYNDROME AND DYSLIPIDEMIA: A SUBANALYSIS OF THE HIJ-PROPER STUDY
    Sekiguchi, Haruki
    Matsui, Yuko
    Kawada-Watanabe, Erisa
    Yamaguchi, Junichi
    Arashi, Hiroyuki
    Ogawa, Hiroshi
    Hagiwara, Nobuhisa
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 71 (11) : 1758 - 1758
  • [40] Characterization of the cholesterol efflux of apolipoprotein E-containing high-density lipoprotein in THP-1 cells
    Horiuchi, Yuna
    Ohkawa, Ryunosuke
    Lai, Shao-Jui
    Yamazaki, Azusa
    Ikoma, Hayato
    Yano, Kouji
    Kameda, Takahiro
    Tozuka, Minoru
    BIOLOGICAL CHEMISTRY, 2019, 400 (02) : 209 - 218
12345